At a certain level, ROS works as an indicator molecule for activating acclimatory/protection responses through transduction pathways, where H 2 O 2 acts as a secondary messenger 12,13
The use of GLP-1 agonists may be considered in T1DM patients who are overweight or obese and not at glycemic goals
Caprylic/Capric Triglyceride, Aqua/Water/Eau, Cera Microcristallina/Microcrystalline Wax/Cire Microcristalline, Synthetic Wax, C9-12 Alkane, Tridecyl Trimellitate, Propanediol, Mica, Polyglyceryl-3 Diisostearate, Glycerin, Butylene Glycol, Polyglyceryl-6 Polyricinoleate, Sodium Chloride, 3-O-Ethyl Ascorbic Acid, Tetrahexyldecyl Ascorbate, Caffeine, Tocopherol, Poncirus Trifoliata Fruit Extract, Citrus Nobilis (Mandarin Orange) Fruit Extract, Citrus Paradisi (Grapefruit) Peel Extract, Jojoba Esters, Ethylhexylglycerin, Sodium Phytate, Polysilicone-11, Phenoxyethanol, Tin Oxide, Iron Oxides (Ci 77491, Ci 77492, Ci 77499), Titanium Dioxide (Ci 77891)
Diabetes Obes Metab 20(Suppl 1):521 Drucker DJ (2022) GLP-1 physiology informs the pharmacotherapy of obesity